Global CAR T-Cell Immunotherapy Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of CAR T-Cell Immunotherapy will have significant change from previous year. According to our (LP Information) latest study, the global CAR T-Cell Immunotherapy market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global CAR T-Cell Immunotherapy market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States CAR T-Cell Immunotherapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global CAR T-Cell Immunotherapy market, reaching US$ million by the year 2028. As for the Europe CAR T-Cell Immunotherapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main CAR T-Cell Immunotherapy players cover AbbVie, Celgene, Kite Pharma, and Oxford BioMedica, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR T-Cell Immunotherapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
As the global economy mends, the 2021 growth of CAR T-Cell Immunotherapy will have significant change from previous year. According to our (LP Information) latest study, the global CAR T-Cell Immunotherapy market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global CAR T-Cell Immunotherapy market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States CAR T-Cell Immunotherapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global CAR T-Cell Immunotherapy market, reaching US$ million by the year 2028. As for the Europe CAR T-Cell Immunotherapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main CAR T-Cell Immunotherapy players cover AbbVie, Celgene, Kite Pharma, and Oxford BioMedica, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR T-Cell Immunotherapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Monotherapy
- Combination Therapy
- Hematologic Malignancies
- Solid Malignancies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie
- Celgene
- Kite Pharma
- Oxford BioMedica
- Novartis
- Gilead
- Pfizer
- Cellectis
- Bellicum
- Mustang Bio
- CARsgen Therapeutics
- Xyphos
- Minerva Biotechnologies
- Adaptimmune
- Ziopharm Oncology
- Aurora Biopharma
- Creative Biolabs
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR T-Cell Immunotherapy Market Size 2017-2028
2.1.2 CAR T-Cell Immunotherapy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 CAR T-Cell Immunotherapy Segment by Type
2.2.1 Monotherapy
2.2.2 Combination Therapy
2.3 CAR T-Cell Immunotherapy Market Size by Type
2.3.1 CAR T-Cell Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)
2.4 CAR T-Cell Immunotherapy Segment by Application
2.4.1 Hematologic Malignancies
2.4.2 Solid Malignancies
2.5 CAR T-Cell Immunotherapy Market Size by Application
2.5.1 CAR T-Cell Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)
3 CAR T-CELL IMMUNOTHERAPY MARKET SIZE BY PLAYER
3.1 CAR T-Cell Immunotherapy Market Size Market Share by Players
3.1.1 Global CAR T-Cell Immunotherapy Revenue by Players (2020-2022)
3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Players (2020-2022)
3.2 Global CAR T-Cell Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR T-CELL IMMUNOTHERAPY BY REGIONS
4.1 CAR T-Cell Immunotherapy Market Size by Regions (2017-2022)
4.2 Americas CAR T-Cell Immunotherapy Market Size Growth (2017-2022)
4.3 APAC CAR T-Cell Immunotherapy Market Size Growth (2017-2022)
4.4 Europe CAR T-Cell Immunotherapy Market Size Growth (2017-2022)
4.5 Middle East & Africa CAR T-Cell Immunotherapy Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas CAR T-Cell Immunotherapy Market Size by Country (2017-2022)
5.2 Americas CAR T-Cell Immunotherapy Market Size by Type (2017-2022)
5.3 Americas CAR T-Cell Immunotherapy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR T-Cell Immunotherapy Market Size by Region (2017-2022)
6.2 APAC CAR T-Cell Immunotherapy Market Size by Type (2017-2022)
6.3 APAC CAR T-Cell Immunotherapy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CAR T-Cell Immunotherapy by Country (2017-2022)
7.2 Europe CAR T-Cell Immunotherapy Market Size by Type (2017-2022)
7.3 Europe CAR T-Cell Immunotherapy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR T-Cell Immunotherapy by Region (2017-2022)
8.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2017-2022)
8.3 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CAR T-CELL IMMUNOTHERAPY MARKET FORECAST
10.1 Global CAR T-Cell Immunotherapy Forecast by Regions (2023-2028)
10.1.1 Global CAR T-Cell Immunotherapy Forecast by Regions (2023-2028)
10.1.2 Americas CAR T-Cell Immunotherapy Forecast
10.1.3 APAC CAR T-Cell Immunotherapy Forecast
10.1.4 Europe CAR T-Cell Immunotherapy Forecast
10.1.5 Middle East & Africa CAR T-Cell Immunotherapy Forecast
10.2 Americas CAR T-Cell Immunotherapy Forecast by Country (2023-2028)
10.2.1 United States CAR T-Cell Immunotherapy Market Forecast
10.2.2 Canada CAR T-Cell Immunotherapy Market Forecast
10.2.3 Mexico CAR T-Cell Immunotherapy Market Forecast
10.2.4 Brazil CAR T-Cell Immunotherapy Market Forecast
10.3 APAC CAR T-Cell Immunotherapy Forecast by Region (2023-2028)
10.3.1 China CAR T-Cell Immunotherapy Market Forecast
10.3.2 Japan CAR T-Cell Immunotherapy Market Forecast
10.3.3 Korea CAR T-Cell Immunotherapy Market Forecast
10.3.4 Southeast Asia CAR T-Cell Immunotherapy Market Forecast
10.3.5 India CAR T-Cell Immunotherapy Market Forecast
10.3.6 Australia CAR T-Cell Immunotherapy Market Forecast
10.4 Europe CAR T-Cell Immunotherapy Forecast by Country (2023-2028)
10.4.1 Germany CAR T-Cell Immunotherapy Market Forecast
10.4.2 France CAR T-Cell Immunotherapy Market Forecast
10.4.3 UK CAR T-Cell Immunotherapy Market Forecast
10.4.4 Italy CAR T-Cell Immunotherapy Market Forecast
10.4.5 Russia CAR T-Cell Immunotherapy Market Forecast
10.5 Middle East & Africa CAR T-Cell Immunotherapy Forecast by Region (2023-2028)
10.5.1 Egypt CAR T-Cell Immunotherapy Market Forecast
10.5.2 South Africa CAR T-Cell Immunotherapy Market Forecast
10.5.3 Israel CAR T-Cell Immunotherapy Market Forecast
10.5.4 Turkey CAR T-Cell Immunotherapy Market Forecast
10.5.5 GCC Countries CAR T-Cell Immunotherapy Market Forecast
10.6 Global CAR T-Cell Immunotherapy Forecast by Type (2023-2028)
10.7 Global CAR T-Cell Immunotherapy Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie CAR T-Cell Immunotherapy Product Offered
11.1.3 AbbVie CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Celgene
11.2.1 Celgene Company Information
11.2.2 Celgene CAR T-Cell Immunotherapy Product Offered
11.2.3 Celgene CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Celgene Main Business Overview
11.2.5 Celgene Latest Developments
11.3 Kite Pharma
11.3.1 Kite Pharma Company Information
11.3.2 Kite Pharma CAR T-Cell Immunotherapy Product Offered
11.3.3 Kite Pharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Kite Pharma Main Business Overview
11.3.5 Kite Pharma Latest Developments
11.4 Oxford BioMedica
11.4.1 Oxford BioMedica Company Information
11.4.2 Oxford BioMedica CAR T-Cell Immunotherapy Product Offered
11.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Oxford BioMedica Main Business Overview
11.4.5 Oxford BioMedica Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis CAR T-Cell Immunotherapy Product Offered
11.5.3 Novartis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 Gilead
11.6.1 Gilead Company Information
11.6.2 Gilead CAR T-Cell Immunotherapy Product Offered
11.6.3 Gilead CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Gilead Main Business Overview
11.6.5 Gilead Latest Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer CAR T-Cell Immunotherapy Product Offered
11.7.3 Pfizer CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Pfizer Main Business Overview
11.7.5 Pfizer Latest Developments
11.8 Cellectis
11.8.1 Cellectis Company Information
11.8.2 Cellectis CAR T-Cell Immunotherapy Product Offered
11.8.3 Cellectis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Cellectis Main Business Overview
11.8.5 Cellectis Latest Developments
11.9 Bellicum
11.9.1 Bellicum Company Information
11.9.2 Bellicum CAR T-Cell Immunotherapy Product Offered
11.9.3 Bellicum CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Bellicum Main Business Overview
11.9.5 Bellicum Latest Developments
11.10 Mustang Bio
11.10.1 Mustang Bio Company Information
11.10.2 Mustang Bio CAR T-Cell Immunotherapy Product Offered
11.10.3 Mustang Bio CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Mustang Bio Main Business Overview
11.10.5 Mustang Bio Latest Developments
11.11 CARsgen Therapeutics
11.11.1 CARsgen Therapeutics Company Information
11.11.2 CARsgen Therapeutics CAR T-Cell Immunotherapy Product Offered
11.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 CARsgen Therapeutics Main Business Overview
11.11.5 CARsgen Therapeutics Latest Developments
11.12 Xyphos
11.12.1 Xyphos Company Information
11.12.2 Xyphos CAR T-Cell Immunotherapy Product Offered
11.12.3 Xyphos CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Xyphos Main Business Overview
11.12.5 Xyphos Latest Developments
11.13 Minerva Biotechnologies
11.13.1 Minerva Biotechnologies Company Information
11.13.2 Minerva Biotechnologies CAR T-Cell Immunotherapy Product Offered
11.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Minerva Biotechnologies Main Business Overview
11.13.5 Minerva Biotechnologies Latest Developments
11.14 Adaptimmune
11.14.1 Adaptimmune Company Information
11.14.2 Adaptimmune CAR T-Cell Immunotherapy Product Offered
11.14.3 Adaptimmune CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Adaptimmune Main Business Overview
11.14.5 Adaptimmune Latest Developments
11.15 Ziopharm Oncology
11.15.1 Ziopharm Oncology Company Information
11.15.2 Ziopharm Oncology CAR T-Cell Immunotherapy Product Offered
11.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Ziopharm Oncology Main Business Overview
11.15.5 Ziopharm Oncology Latest Developments
11.16 Aurora Biopharma
11.16.1 Aurora Biopharma Company Information
11.16.2 Aurora Biopharma CAR T-Cell Immunotherapy Product Offered
11.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Aurora Biopharma Main Business Overview
11.16.5 Aurora Biopharma Latest Developments
11.17 Creative Biolabs
11.17.1 Creative Biolabs Company Information
11.17.2 Creative Biolabs CAR T-Cell Immunotherapy Product Offered
11.17.3 Creative Biolabs CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Creative Biolabs Main Business Overview
11.17.5 Creative Biolabs Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR T-Cell Immunotherapy Market Size 2017-2028
2.1.2 CAR T-Cell Immunotherapy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 CAR T-Cell Immunotherapy Segment by Type
2.2.1 Monotherapy
2.2.2 Combination Therapy
2.3 CAR T-Cell Immunotherapy Market Size by Type
2.3.1 CAR T-Cell Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)
2.4 CAR T-Cell Immunotherapy Segment by Application
2.4.1 Hematologic Malignancies
2.4.2 Solid Malignancies
2.5 CAR T-Cell Immunotherapy Market Size by Application
2.5.1 CAR T-Cell Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)
3 CAR T-CELL IMMUNOTHERAPY MARKET SIZE BY PLAYER
3.1 CAR T-Cell Immunotherapy Market Size Market Share by Players
3.1.1 Global CAR T-Cell Immunotherapy Revenue by Players (2020-2022)
3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Players (2020-2022)
3.2 Global CAR T-Cell Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR T-CELL IMMUNOTHERAPY BY REGIONS
4.1 CAR T-Cell Immunotherapy Market Size by Regions (2017-2022)
4.2 Americas CAR T-Cell Immunotherapy Market Size Growth (2017-2022)
4.3 APAC CAR T-Cell Immunotherapy Market Size Growth (2017-2022)
4.4 Europe CAR T-Cell Immunotherapy Market Size Growth (2017-2022)
4.5 Middle East & Africa CAR T-Cell Immunotherapy Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas CAR T-Cell Immunotherapy Market Size by Country (2017-2022)
5.2 Americas CAR T-Cell Immunotherapy Market Size by Type (2017-2022)
5.3 Americas CAR T-Cell Immunotherapy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR T-Cell Immunotherapy Market Size by Region (2017-2022)
6.2 APAC CAR T-Cell Immunotherapy Market Size by Type (2017-2022)
6.3 APAC CAR T-Cell Immunotherapy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CAR T-Cell Immunotherapy by Country (2017-2022)
7.2 Europe CAR T-Cell Immunotherapy Market Size by Type (2017-2022)
7.3 Europe CAR T-Cell Immunotherapy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR T-Cell Immunotherapy by Region (2017-2022)
8.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2017-2022)
8.3 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CAR T-CELL IMMUNOTHERAPY MARKET FORECAST
10.1 Global CAR T-Cell Immunotherapy Forecast by Regions (2023-2028)
10.1.1 Global CAR T-Cell Immunotherapy Forecast by Regions (2023-2028)
10.1.2 Americas CAR T-Cell Immunotherapy Forecast
10.1.3 APAC CAR T-Cell Immunotherapy Forecast
10.1.4 Europe CAR T-Cell Immunotherapy Forecast
10.1.5 Middle East & Africa CAR T-Cell Immunotherapy Forecast
10.2 Americas CAR T-Cell Immunotherapy Forecast by Country (2023-2028)
10.2.1 United States CAR T-Cell Immunotherapy Market Forecast
10.2.2 Canada CAR T-Cell Immunotherapy Market Forecast
10.2.3 Mexico CAR T-Cell Immunotherapy Market Forecast
10.2.4 Brazil CAR T-Cell Immunotherapy Market Forecast
10.3 APAC CAR T-Cell Immunotherapy Forecast by Region (2023-2028)
10.3.1 China CAR T-Cell Immunotherapy Market Forecast
10.3.2 Japan CAR T-Cell Immunotherapy Market Forecast
10.3.3 Korea CAR T-Cell Immunotherapy Market Forecast
10.3.4 Southeast Asia CAR T-Cell Immunotherapy Market Forecast
10.3.5 India CAR T-Cell Immunotherapy Market Forecast
10.3.6 Australia CAR T-Cell Immunotherapy Market Forecast
10.4 Europe CAR T-Cell Immunotherapy Forecast by Country (2023-2028)
10.4.1 Germany CAR T-Cell Immunotherapy Market Forecast
10.4.2 France CAR T-Cell Immunotherapy Market Forecast
10.4.3 UK CAR T-Cell Immunotherapy Market Forecast
10.4.4 Italy CAR T-Cell Immunotherapy Market Forecast
10.4.5 Russia CAR T-Cell Immunotherapy Market Forecast
10.5 Middle East & Africa CAR T-Cell Immunotherapy Forecast by Region (2023-2028)
10.5.1 Egypt CAR T-Cell Immunotherapy Market Forecast
10.5.2 South Africa CAR T-Cell Immunotherapy Market Forecast
10.5.3 Israel CAR T-Cell Immunotherapy Market Forecast
10.5.4 Turkey CAR T-Cell Immunotherapy Market Forecast
10.5.5 GCC Countries CAR T-Cell Immunotherapy Market Forecast
10.6 Global CAR T-Cell Immunotherapy Forecast by Type (2023-2028)
10.7 Global CAR T-Cell Immunotherapy Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie CAR T-Cell Immunotherapy Product Offered
11.1.3 AbbVie CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Celgene
11.2.1 Celgene Company Information
11.2.2 Celgene CAR T-Cell Immunotherapy Product Offered
11.2.3 Celgene CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Celgene Main Business Overview
11.2.5 Celgene Latest Developments
11.3 Kite Pharma
11.3.1 Kite Pharma Company Information
11.3.2 Kite Pharma CAR T-Cell Immunotherapy Product Offered
11.3.3 Kite Pharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Kite Pharma Main Business Overview
11.3.5 Kite Pharma Latest Developments
11.4 Oxford BioMedica
11.4.1 Oxford BioMedica Company Information
11.4.2 Oxford BioMedica CAR T-Cell Immunotherapy Product Offered
11.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Oxford BioMedica Main Business Overview
11.4.5 Oxford BioMedica Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis CAR T-Cell Immunotherapy Product Offered
11.5.3 Novartis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 Gilead
11.6.1 Gilead Company Information
11.6.2 Gilead CAR T-Cell Immunotherapy Product Offered
11.6.3 Gilead CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Gilead Main Business Overview
11.6.5 Gilead Latest Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer CAR T-Cell Immunotherapy Product Offered
11.7.3 Pfizer CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Pfizer Main Business Overview
11.7.5 Pfizer Latest Developments
11.8 Cellectis
11.8.1 Cellectis Company Information
11.8.2 Cellectis CAR T-Cell Immunotherapy Product Offered
11.8.3 Cellectis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Cellectis Main Business Overview
11.8.5 Cellectis Latest Developments
11.9 Bellicum
11.9.1 Bellicum Company Information
11.9.2 Bellicum CAR T-Cell Immunotherapy Product Offered
11.9.3 Bellicum CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Bellicum Main Business Overview
11.9.5 Bellicum Latest Developments
11.10 Mustang Bio
11.10.1 Mustang Bio Company Information
11.10.2 Mustang Bio CAR T-Cell Immunotherapy Product Offered
11.10.3 Mustang Bio CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Mustang Bio Main Business Overview
11.10.5 Mustang Bio Latest Developments
11.11 CARsgen Therapeutics
11.11.1 CARsgen Therapeutics Company Information
11.11.2 CARsgen Therapeutics CAR T-Cell Immunotherapy Product Offered
11.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 CARsgen Therapeutics Main Business Overview
11.11.5 CARsgen Therapeutics Latest Developments
11.12 Xyphos
11.12.1 Xyphos Company Information
11.12.2 Xyphos CAR T-Cell Immunotherapy Product Offered
11.12.3 Xyphos CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Xyphos Main Business Overview
11.12.5 Xyphos Latest Developments
11.13 Minerva Biotechnologies
11.13.1 Minerva Biotechnologies Company Information
11.13.2 Minerva Biotechnologies CAR T-Cell Immunotherapy Product Offered
11.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Minerva Biotechnologies Main Business Overview
11.13.5 Minerva Biotechnologies Latest Developments
11.14 Adaptimmune
11.14.1 Adaptimmune Company Information
11.14.2 Adaptimmune CAR T-Cell Immunotherapy Product Offered
11.14.3 Adaptimmune CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Adaptimmune Main Business Overview
11.14.5 Adaptimmune Latest Developments
11.15 Ziopharm Oncology
11.15.1 Ziopharm Oncology Company Information
11.15.2 Ziopharm Oncology CAR T-Cell Immunotherapy Product Offered
11.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Ziopharm Oncology Main Business Overview
11.15.5 Ziopharm Oncology Latest Developments
11.16 Aurora Biopharma
11.16.1 Aurora Biopharma Company Information
11.16.2 Aurora Biopharma CAR T-Cell Immunotherapy Product Offered
11.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Aurora Biopharma Main Business Overview
11.16.5 Aurora Biopharma Latest Developments
11.17 Creative Biolabs
11.17.1 Creative Biolabs Company Information
11.17.2 Creative Biolabs CAR T-Cell Immunotherapy Product Offered
11.17.3 Creative Biolabs CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Creative Biolabs Main Business Overview
11.17.5 Creative Biolabs Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. CAR T-Cell Immunotherapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Monotherapy
Table 3. Major Players of Combination Therapy
Table 4. CAR T-Cell Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 7. CAR T-Cell Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 10. Global CAR T-Cell Immunotherapy Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global CAR T-Cell Immunotherapy Revenue Market Share by Player (2020-2022)
Table 12. CAR T-Cell Immunotherapy Key Players Head office and Products Offered
Table 13. CAR T-Cell Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global CAR T-Cell Immunotherapy Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global CAR T-Cell Immunotherapy Market Size Market Share by Regions (2017-2022)
Table 18. Americas CAR T-Cell Immunotherapy Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas CAR T-Cell Immunotherapy Market Size Market Share by Country (2017-2022)
Table 20. Americas CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 22. Americas CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 24. APAC CAR T-Cell Immunotherapy Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC CAR T-Cell Immunotherapy Market Size Market Share by Region (2017-2022)
Table 26. APAC CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 28. APAC CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 30. Europe CAR T-Cell Immunotherapy Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe CAR T-Cell Immunotherapy Market Size Market Share by Country (2017-2022)
Table 32. Europe CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 34. Europe CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa CAR T-Cell Immunotherapy Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of CAR T-Cell Immunotherapy
Table 43. Key Market Challenges & Risks of CAR T-Cell Immunotherapy
Table 44. Key Industry Trends of CAR T-Cell Immunotherapy
Table 45. Global CAR T-Cell Immunotherapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global CAR T-Cell Immunotherapy Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global CAR T-Cell Immunotherapy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global CAR T-Cell Immunotherapy Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global CAR T-Cell Immunotherapy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global CAR T-Cell Immunotherapy Market Size Market Share Forecast by Application (2023-2028)
Table 51. AbbVie Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 52. AbbVie CAR T-Cell Immunotherapy Product Offered
Table 53. AbbVie CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. AbbVie Main Business
Table 55. AbbVie Latest Developments
Table 56. Celgene Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 57. Celgene CAR T-Cell Immunotherapy Product Offered
Table 58. Celgene Main Business
Table 59. Celgene CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Celgene Latest Developments
Table 61. Kite Pharma Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 62. Kite Pharma CAR T-Cell Immunotherapy Product Offered
Table 63. Kite Pharma Main Business
Table 64. Kite Pharma CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Kite Pharma Latest Developments
Table 66. Oxford BioMedica Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 67. Oxford BioMedica CAR T-Cell Immunotherapy Product Offered
Table 68. Oxford BioMedica Main Business
Table 69. Oxford BioMedica CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Oxford BioMedica Latest Developments
Table 71. Novartis Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 72. Novartis CAR T-Cell Immunotherapy Product Offered
Table 73. Novartis Main Business
Table 74. Novartis CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Novartis Latest Developments
Table 76. Gilead Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 77. Gilead CAR T-Cell Immunotherapy Product Offered
Table 78. Gilead Main Business
Table 79. Gilead CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Gilead Latest Developments
Table 81. Pfizer Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 82. Pfizer CAR T-Cell Immunotherapy Product Offered
Table 83. Pfizer Main Business
Table 84. Pfizer CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Pfizer Latest Developments
Table 86. Cellectis Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 87. Cellectis CAR T-Cell Immunotherapy Product Offered
Table 88. Cellectis Main Business
Table 89. Cellectis CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Cellectis Latest Developments
Table 91. Bellicum Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 92. Bellicum CAR T-Cell Immunotherapy Product Offered
Table 93. Bellicum Main Business
Table 94. Bellicum CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Bellicum Latest Developments
Table 96. Mustang Bio Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 97. Mustang Bio CAR T-Cell Immunotherapy Product Offered
Table 98. Mustang Bio Main Business
Table 99. Mustang Bio CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Mustang Bio Latest Developments
Table 101. CARsgen Therapeutics Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 102. CARsgen Therapeutics CAR T-Cell Immunotherapy Product Offered
Table 103. CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. CARsgen Therapeutics Main Business
Table 105. CARsgen Therapeutics Latest Developments
Table 106. Xyphos Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 107. Xyphos CAR T-Cell Immunotherapy Product Offered
Table 108. Xyphos Main Business
Table 109. Xyphos CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Xyphos Latest Developments
Table 111. Minerva Biotechnologies Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 112. Minerva Biotechnologies CAR T-Cell Immunotherapy Product Offered
Table 113. Minerva Biotechnologies Main Business
Table 114. Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Minerva Biotechnologies Latest Developments
Table 116. Adaptimmune Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 117. Adaptimmune CAR T-Cell Immunotherapy Product Offered
Table 118. Adaptimmune Main Business
Table 119. Adaptimmune CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Adaptimmune Latest Developments
Table 121. Ziopharm Oncology Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 122. Ziopharm Oncology CAR T-Cell Immunotherapy Product Offered
Table 123. Ziopharm Oncology Main Business
Table 124. Ziopharm Oncology CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. Ziopharm Oncology Latest Developments
Table 126. Aurora Biopharma Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 127. Aurora Biopharma CAR T-Cell Immunotherapy Product Offered
Table 128. Aurora Biopharma Main Business
Table 129. Aurora Biopharma CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. Aurora Biopharma Latest Developments
Table 131. Creative Biolabs Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 132. Creative Biolabs CAR T-Cell Immunotherapy Product Offered
Table 133. Creative Biolabs Main Business
Table 134. Creative Biolabs CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. Creative Biolabs Latest Developments
Table 1. CAR T-Cell Immunotherapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Monotherapy
Table 3. Major Players of Combination Therapy
Table 4. CAR T-Cell Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 7. CAR T-Cell Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 10. Global CAR T-Cell Immunotherapy Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global CAR T-Cell Immunotherapy Revenue Market Share by Player (2020-2022)
Table 12. CAR T-Cell Immunotherapy Key Players Head office and Products Offered
Table 13. CAR T-Cell Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global CAR T-Cell Immunotherapy Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global CAR T-Cell Immunotherapy Market Size Market Share by Regions (2017-2022)
Table 18. Americas CAR T-Cell Immunotherapy Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas CAR T-Cell Immunotherapy Market Size Market Share by Country (2017-2022)
Table 20. Americas CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 22. Americas CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 24. APAC CAR T-Cell Immunotherapy Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC CAR T-Cell Immunotherapy Market Size Market Share by Region (2017-2022)
Table 26. APAC CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 28. APAC CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 30. Europe CAR T-Cell Immunotherapy Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe CAR T-Cell Immunotherapy Market Size Market Share by Country (2017-2022)
Table 32. Europe CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 34. Europe CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa CAR T-Cell Immunotherapy Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa CAR T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa CAR T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of CAR T-Cell Immunotherapy
Table 43. Key Market Challenges & Risks of CAR T-Cell Immunotherapy
Table 44. Key Industry Trends of CAR T-Cell Immunotherapy
Table 45. Global CAR T-Cell Immunotherapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global CAR T-Cell Immunotherapy Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global CAR T-Cell Immunotherapy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global CAR T-Cell Immunotherapy Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global CAR T-Cell Immunotherapy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global CAR T-Cell Immunotherapy Market Size Market Share Forecast by Application (2023-2028)
Table 51. AbbVie Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 52. AbbVie CAR T-Cell Immunotherapy Product Offered
Table 53. AbbVie CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. AbbVie Main Business
Table 55. AbbVie Latest Developments
Table 56. Celgene Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 57. Celgene CAR T-Cell Immunotherapy Product Offered
Table 58. Celgene Main Business
Table 59. Celgene CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Celgene Latest Developments
Table 61. Kite Pharma Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 62. Kite Pharma CAR T-Cell Immunotherapy Product Offered
Table 63. Kite Pharma Main Business
Table 64. Kite Pharma CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Kite Pharma Latest Developments
Table 66. Oxford BioMedica Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 67. Oxford BioMedica CAR T-Cell Immunotherapy Product Offered
Table 68. Oxford BioMedica Main Business
Table 69. Oxford BioMedica CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Oxford BioMedica Latest Developments
Table 71. Novartis Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 72. Novartis CAR T-Cell Immunotherapy Product Offered
Table 73. Novartis Main Business
Table 74. Novartis CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Novartis Latest Developments
Table 76. Gilead Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 77. Gilead CAR T-Cell Immunotherapy Product Offered
Table 78. Gilead Main Business
Table 79. Gilead CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Gilead Latest Developments
Table 81. Pfizer Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 82. Pfizer CAR T-Cell Immunotherapy Product Offered
Table 83. Pfizer Main Business
Table 84. Pfizer CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Pfizer Latest Developments
Table 86. Cellectis Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 87. Cellectis CAR T-Cell Immunotherapy Product Offered
Table 88. Cellectis Main Business
Table 89. Cellectis CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Cellectis Latest Developments
Table 91. Bellicum Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 92. Bellicum CAR T-Cell Immunotherapy Product Offered
Table 93. Bellicum Main Business
Table 94. Bellicum CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Bellicum Latest Developments
Table 96. Mustang Bio Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 97. Mustang Bio CAR T-Cell Immunotherapy Product Offered
Table 98. Mustang Bio Main Business
Table 99. Mustang Bio CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Mustang Bio Latest Developments
Table 101. CARsgen Therapeutics Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 102. CARsgen Therapeutics CAR T-Cell Immunotherapy Product Offered
Table 103. CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. CARsgen Therapeutics Main Business
Table 105. CARsgen Therapeutics Latest Developments
Table 106. Xyphos Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 107. Xyphos CAR T-Cell Immunotherapy Product Offered
Table 108. Xyphos Main Business
Table 109. Xyphos CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Xyphos Latest Developments
Table 111. Minerva Biotechnologies Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 112. Minerva Biotechnologies CAR T-Cell Immunotherapy Product Offered
Table 113. Minerva Biotechnologies Main Business
Table 114. Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Minerva Biotechnologies Latest Developments
Table 116. Adaptimmune Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 117. Adaptimmune CAR T-Cell Immunotherapy Product Offered
Table 118. Adaptimmune Main Business
Table 119. Adaptimmune CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Adaptimmune Latest Developments
Table 121. Ziopharm Oncology Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 122. Ziopharm Oncology CAR T-Cell Immunotherapy Product Offered
Table 123. Ziopharm Oncology Main Business
Table 124. Ziopharm Oncology CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. Ziopharm Oncology Latest Developments
Table 126. Aurora Biopharma Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 127. Aurora Biopharma CAR T-Cell Immunotherapy Product Offered
Table 128. Aurora Biopharma Main Business
Table 129. Aurora Biopharma CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. Aurora Biopharma Latest Developments
Table 131. Creative Biolabs Details, Company Type, CAR T-Cell Immunotherapy Area Served and Its Competitors
Table 132. Creative Biolabs CAR T-Cell Immunotherapy Product Offered
Table 133. Creative Biolabs Main Business
Table 134. Creative Biolabs CAR T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. Creative Biolabs Latest Developments
LIST OF FIGURES
Figure 1. CAR T-Cell Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR T-Cell Immunotherapy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global CAR T-Cell Immunotherapy Market Size Market Share by Type in 2021
Figure 7. CAR T-Cell Immunotherapy in Hematologic Malignancies
Figure 8. Global CAR T-Cell Immunotherapy Market: Hematologic Malignancies (2017-2022) & ($ Millions)
Figure 9. CAR T-Cell Immunotherapy in Solid Malignancies
Figure 10. Global CAR T-Cell Immunotherapy Market: Solid Malignancies (2017-2022) & ($ Millions)
Figure 11. Global CAR T-Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 12. Global CAR T-Cell Immunotherapy Revenue Market Share by Player in 2021
Figure 13. Global CAR T-Cell Immunotherapy Market Size Market Share by Regions (2017-2022)
Figure 14. Americas CAR T-Cell Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 15. APAC CAR T-Cell Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 16. Europe CAR T-Cell Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa CAR T-Cell Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 18. Americas CAR T-Cell Immunotherapy Value Market Share by Country in 2021
Figure 19. Americas CAR T-Cell Immunotherapy Consumption Market Share by Type in 2021
Figure 20. Americas CAR T-Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 21. United States CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC CAR T-Cell Immunotherapy Market Size Market Share by Region in 2021
Figure 26. APAC CAR T-Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 27. China CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 31. India CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe CAR T-Cell Immunotherapy Market Size Market Share by Country in 2021
Figure 34. Europe CAR T-Cell Immunotherapy Market Size Market Share by Type in 2021
Figure 35. Europe CAR T-Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 36. Germany CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 37. France CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa CAR T-Cell Immunotherapy Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa CAR T-Cell Immunotherapy Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa CAR T-Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 44. Egypt CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 50. APAC CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 51. Europe CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 53. United States CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 54. Canada CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 55. Mexico CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 56. Brazil CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 57. China CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 58. Japan CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 59. Korea CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 61. India CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 62. Australia CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 63. Germany CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 64. France CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 65. UK CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 66. Italy CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 67. Russia CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 68. Spain CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 69. Egypt CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 70. South Africa CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 71. Israel CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 72. Turkey CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 1. CAR T-Cell Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR T-Cell Immunotherapy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global CAR T-Cell Immunotherapy Market Size Market Share by Type in 2021
Figure 7. CAR T-Cell Immunotherapy in Hematologic Malignancies
Figure 8. Global CAR T-Cell Immunotherapy Market: Hematologic Malignancies (2017-2022) & ($ Millions)
Figure 9. CAR T-Cell Immunotherapy in Solid Malignancies
Figure 10. Global CAR T-Cell Immunotherapy Market: Solid Malignancies (2017-2022) & ($ Millions)
Figure 11. Global CAR T-Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 12. Global CAR T-Cell Immunotherapy Revenue Market Share by Player in 2021
Figure 13. Global CAR T-Cell Immunotherapy Market Size Market Share by Regions (2017-2022)
Figure 14. Americas CAR T-Cell Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 15. APAC CAR T-Cell Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 16. Europe CAR T-Cell Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa CAR T-Cell Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 18. Americas CAR T-Cell Immunotherapy Value Market Share by Country in 2021
Figure 19. Americas CAR T-Cell Immunotherapy Consumption Market Share by Type in 2021
Figure 20. Americas CAR T-Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 21. United States CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC CAR T-Cell Immunotherapy Market Size Market Share by Region in 2021
Figure 26. APAC CAR T-Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 27. China CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 31. India CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe CAR T-Cell Immunotherapy Market Size Market Share by Country in 2021
Figure 34. Europe CAR T-Cell Immunotherapy Market Size Market Share by Type in 2021
Figure 35. Europe CAR T-Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 36. Germany CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 37. France CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa CAR T-Cell Immunotherapy Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa CAR T-Cell Immunotherapy Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa CAR T-Cell Immunotherapy Market Size Market Share by Application in 2021
Figure 44. Egypt CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country CAR T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 50. APAC CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 51. Europe CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 53. United States CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 54. Canada CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 55. Mexico CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 56. Brazil CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 57. China CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 58. Japan CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 59. Korea CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 61. India CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 62. Australia CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 63. Germany CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 64. France CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 65. UK CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 66. Italy CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 67. Russia CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 68. Spain CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 69. Egypt CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 70. South Africa CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 71. Israel CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 72. Turkey CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries CAR T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)
